Integra LifeSciences reported a 2.4% increase in first-quarter 2026 revenues to $391.9 million, driven by strong demand in tissue reconstruction and neurosurgery products. Adjusted earnings per share rose to $0.54 from $0.41 last year, while GAAP net loss narrowed significantly. The company reaffirmed its full-year revenue guidance of $1.662-$1.702 billion and raised adjusted EPS guidance to $2.40-$2.50, citing improved operational execution and supply reliability. New CEO Stuart Essig highlighted progress in manufacturing and product launches, with confidence in meeting full-year targets.
KEPPT has appointed J.P. Morgan to arrange financing for a $1.6 billion urea plant in Basra, Iraq, aiming to reduce reliance on imports and support the agricultural sector. The plant will produce 1.15 million tonnes annually and is expected to start ...
KAR Electrical Power Production Trading FZE (KEPPT) has appointed J.P. Morgan to coordinate financing for its $1.6 billion urea plant in Basra, Iraq. The plant, expected to start construction in 2027 and operation by 2030, will produce 1.15 million t...
KEPPT has appointed J.P. Morgan to arrange financing for a $1.6 billion urea plant in Basra, Iraq, set to produce 1.15 million tonnes annually. This project aims to reduce Iraq's dependence on urea imports, support the agricultural sector, and stimul...
Atos has introduced Atos MogwAI, a comprehensive sovereign AI platform designed to help organizations scale AI adoption securely and compliantly. The platform supports end-to-end AI integration, leveraging internal data and processes to create specia...
Investec Bank plc, acting as joint broker to Gamma Communications Plc, disclosed public dealings in Gamma Communications' ordinary shares on July 6, 2026. The bank purchased 41,187 shares and sold 40,970 shares at prices ranging between 825.5 and 854...
